The problem usually isn’t the clinical strategy. It’s what happens after the strategy is approved. When priorities blur, ownership fragments and progress goes unmeasured, even well-designed plans stall before they reach members. The downstream effects — avoidable utilization, missed engagement…
- Deb Vona
- Deborah Stewart, MD
- Katherine Musler
- Vimbai Mudimu
